The CALLY index, a biomarker that examines systemic inflammation, immune system activity and nutrition, could provide care teams with significant value.

New SCCT president Ronen Rubinshtein, MD, says the fields of interventional cardiology and cardiac imaging are two of his greatest interests. 

The lawsuit Hemal Gada, MD, filed against UPMC has been dismissed with prejudice. 

Data on the potential relationship between cannabis use and CVD remain mixed. For now, however, there is enough evidence available that heart patients should be careful. 

The AI software, which has already received CE mark approval, provides care teams with a noninvasive way to secure FFR values from routine coronary angiography. 

PAD patients treated with GLP-1 receptor agonists lived longer, stayed out of the hospital more and experienced fewer amputations than those given metformin.

Eight reports of major bleeding have been reported from Impella introducers, prompting the FDA early alert this week. 

Gout often goes undertreated, but targeting these patients with urate-lowering therapy can make a big impact on their long-term cardiovascular health.

Leadless pacing in the Bachmann's bundle may be the next phase in the evolution of cardiac pacing technology.

Managing recurrent prostate cancer after first-line treatment remains a key clinical challenge, experts write in The Journal of Nuclear Medicine. 

Patients increasingly wait for—or never receive—drug treatments deemed appropriate and timely by their doctors.